Canada-wide Implementation of a Virtual Sexual Health and Rehabilitation eClinic (SHAReClinic) for Prostate Cancer Patients and Their Partners
Prostate Cancer | Sexual Dysfunction, Physiological | Sexual Dysfunction | Implementation |...The goal of this observational study is to evaluate the effectiveness of SHAReClinic, a national, virtual Sexual Health and Rehabilitation eClinic designed to support prostate cancer patients and their partners. Specifically, this study aims to assess SHAReClinic's impact on improving sexual function, satisfaction, and relational intimacy after treatment.
The primary objective is to evaluate SHAReClinic's effectiveness across participating sites and determine its role in supporting long-term sexual health and well-being.
As part of usual care, newly enrolled SHAReClinic patients will receive guided education modules and access to sexual health counselling at key recovery milestones.
SHAReClinic seeks to expand access to sexual health care for prostate cancer patients across Canada by providing evidence-based, virtual sexual rehabilitation. Findings from this study will inform best practices in survivorship care and contribute to the development of a national standard for oncology sexual health interventions.
null
Participation Requirements
-
Sex:
MALE -
Eligible Ages:
18 and up
Participation Criteria
Inclusion Criteria:
* Patients who are scheduled for first-line treatment for localized prostate cancer, either through radical prostatectomy (open or robotic) or radiation treatment (brachytherapy, external beam) Alone, or with adjuvant Androgen Deprivation Therapy (ADT) OR
* Patients currently undergoing active treatment for prostate cancer OR
* Patients who have undergone cancer treatment in the past 6 months
* Patients who are hormone and/or chemotherapy-naïve
* Patients who have access to a computer or smartphone with internet access
* Patients who are 18 years of age or older
Exclusion Criteria:
* Patients on ADT alone as primary treatment, and/or patients on chemotherapy
* Patients who lack English proficiency
* Patients on nitrate therapy or have other contra-indications to phosphodiesterase type 5 inhibitors (PDE5i's)
* Patients with medical conditions that would preclude safe sexual activity
* Patients who have had previous treatment for PCa
Study Location
Men's Health Clinic Manitoba
Men's Health Clinic ManitobaWinnipeg, Manitoba
Canada
Contact Study Team
St. Joseph's Health Care London
St. Joseph's Health Care LondonLondon, Ontario
Canada
Contact Study Team
St. Paul's Hospital
St. Paul's HospitalSaskatoon, Saskatchewan
Canada
Contact Study Team
Dianne & Irving Kipnes Urology Centre
Dianne & Irving Kipnes Urology CentreEdmonton, Ontario
Canada
Contact Study Team
Grass Family Men's Health Center
Grass Family Men's Health CenterOttawa, Ontario
Canada
Contact Study Team
Vancouver Coastal Health Authority
Vancouver Coastal Health AuthorityVancouver, British Columbia
Canada
Contact Study Team
Kingston Health Sciences Centre
Kingston Health Sciences CentreKingston, Ontario
Canada
Contact Study Team
University Health Network
University Health NetworkToronto, Ontario
Canada
Contact Study Team
Royal Victoria Regional Health Centre
Royal Victoria Regional Health CentreBarrie, Ontario
Canada
Contact Study Team
Trillium Health Partners
Trillium Health PartnersMississauga, Ontario
Canada
Contact Study Team
- Study Sponsored By
- University Health Network, Toronto
- Participants Required
- More Information
- Study ID:
NCT06877598